TERBINAFINE TEVA 250 mg, scored tablet 28 tablets
Active ingredients: Terbinafine hydrochloride, Terbinafine
Commercialized according to BDPMDispensing in France: Prescription only
Scored tablet28 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TERBINAFINE TEVA 250 mg, comprimé sécable
- Pharmaceutical form
- comprimé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) aluminium PVC PVDC PVC PVDC de 28 comprimé(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 16 Jun 2019
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63760034CIP73802415CIP133400938024159Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE TERBINAFINEcomprimé | — | SA |
| TERBINAFINEcomprimé | 250 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.